IOR – Institute of Oncology Research

Fighting cancer through research

Menu
  • The Institute
    • About
    • Education
    • Staff
    • Jobs
    • Partners
    • Contact
    • Support Us
  • Research
    • Lymphoma and Genomics Research Program
    • Tumor Biology and Experimental Therapeutics Research Program
    • Facilities
      • Bioinformatics Core Unit
      • Genomics Facility
      • Histopathology Facility
      • Preclinical Imaging Facility
  • Groups
    • Cancer Immunotherapy
    • Experimental Hematology
    • Experimental Therapeutics
    • Functional Cancer Genomics
    • Lymphoma Genomics
    • Molecular Oncology
    • Prostate Cancer Biology
  • PhD Program
    • Lecture course 2020-2021
    • Lecture course 2019-2020
    • Lecture course 2018-2019
    • Lecture course 2017-2018
  • Calendar
  • News
  • Scientific Reports

Kokanovic Aleksandra, Research Assistant (animal facility)

Posted on September 4, 2017December 4, 2019 by Isabella Ferrario

Phone: 091 821 0067
Email: aleksandra -dot- kokanovic -at- ior -dot- usi -dot- ch

news

New International PhD Program in Cancer Biology and Oncology 2020-2021
17 Sep

New International PhD Program in Cancer Biology and Oncology 2020-2021

PhD at Institute of Oncology Research (IOR) means ...
EPFL, SUPSI and IOR receive a Swiss National Science Foundation (SNFS) grant within the NRP 78 “Covid-19” programme to develop a microfluidics device to detect SARS-CoV-2 virus
19 Aug

EPFL, SUPSI and IOR receive a Swiss National Science Foundation (SNFS) grant within the NRP 78 “Covid-19” programme to develop a microfluidics device to detect SARS-CoV-2 virus

The project “Development of a microfluidic platfor...
IOR researchers suggest that androgen-deprivation treatments for prostate cancer could protect men from COVID-19
12 May

IOR researchers suggest that androgen-deprivation treatments for prostate cancer could protect men from COVID-19

The so-called "androgen-deprivation" treatments us...
View All
Free WordPress Theme | AccessPress Lite
Copyright © 2020 Institute of Oncology Research